Introduction {#S0001}
============

The mortality rate due to pneumonia has shown little improvement over time despite advances in antimicrobial therapy and improved intensive care medicine \[[@CIT0001]--[@CIT0003]\]. It was as high as 58% when patients with severe community-acquired pneumonia (CAP) were admitted to the intensive care unit (ICU) \[[@CIT0004]\].

The Surviving Sepsis Campaign (SSC) was launched in 2002 as a collaborative initiative of three international organizations. The initial guidelines were published in 2004 and an updated version in 2008. Its objective was, through the development and promulgation of evidence-based guidelines that facilitated the application of knowledge derived from clinical trials to bedside practice, to effect a 25% reduction in the relative risk of death from severe sepsis and septic shock \[[@CIT0005], [@CIT0006]\]. The development and publication of guidelines often do not lead to changes in clinical behaviour and guidelines are rarely, if ever, integrated into bedside practice in a timely fashion. The SSC undertook a broad educational programme to implement them by integrating their recommendations into resuscitation and management bundles. The feasibility of implementing severe sepsis bundles was validated in the United States, Europe and South America and as a result the mortality from severe sepsis was reduced \[[@CIT0007]--[@CIT0019]\]. Compliance with the bundles and its impact were heterogeneous among institutions and countries \[[@CIT0020]\]. Therefore, the primary evidence obtained so far lacks enough substance and quality to promote the guidelines as a global standard of care for universal applicability. Further evaluations and primary studies are still needed \[[@CIT0021]\], especially in countries with limited resources.

There has only been one report so far in English of compliance with the bundles in Asia \[[@CIT0022]\]. The study did not aim to evaluate the impact of the sepsis protocol during a one-month observation period. As the centres included in this study might not be fully representative, achievement rates reported might overestimate or underestimate the true degree of compliance with recommended care and should be interpreted with caution. On the other hand, the healthcare systems in many Asian countries differ greatly from those in the above-mentioned developed countries. Therefore, further studies are still warranted in Asia.

Pneumonia is the major source of infection in severe sepsis patients in our respiratory ICU (RICU). Therefore, we decided to study this population. Adult patients who suffered from severe CAP with severe sepsis or septic shock were enrolled in this study to determine compliance with severe sepsis bundles and to report its effect on patient outcomes in a limited resources country.

Material and methods {#S0002}
====================

Design and setting {#S20003}
------------------

A prospective observational cohort study from 1 November 2006 to 31 July 2008 was carried out on adult patients who met criteria for severe CAP with severe sepsis or septic shock presenting to the RICU in a Chinese affiliated tertiary hospital of a medical college. Similar patients presenting between 1 November 2004 and 31 October 2006 were used as historical controls.

Criteria for enrolment {#S20004}
----------------------

The CAP was defined as an acute infection of the pulmonary parenchyma associated with an acute infiltrate on the chest radiograph with two or more symptoms including fever (\> 38°C), hypothermia (\< 36°C), rigors, sweats, new cough or change in colour of respiratory secretions, chest discomfort or dyspnoea. Severe CAP with severe sepsis or septic shock was defined when one of two major criteria (the need for invasive mechanical ventilation or vasopressors) was fulfilled. Septic shock was defined as systolic arterial pressure (SAP) \< 90 mm Hg, mean arterial pressure (MAP) \< 60 mm Hg, or a reduction in SAP of \> 40 mm Hg from baseline, which was persistent, despite adequate fluid resuscitation, in the absence of other causes for hypotension \[[@CIT0003], [@CIT0023], [@CIT0024]\].

Exclusion criteria were patients who: a) had a cardiac arrest, or b) had end-stage chronic disease (malignancy, chronic renal failure, chronic obstructive pulmonary disease, or acquired immune deficiency syndrome). Patients with severe heart failure, with neoplastic disease (but not in the end stage), with severe asthma, with chronic renal failure stage I, or with brain stroke were also enrolled.

Components of severe sepsis bundles {#S20005}
-----------------------------------

Six-hour and 24-hour severe sepsis bundles adapted from the SSC standard sepsis resuscitation and management bundles are listed in [Table I](#T0001){ref-type="table"} \[[@CIT0025]\]. Since the use of recombinant human activated protein C is not approved in China, it was eliminated from the 24-hour severe sepsis bundle.

###### 

Severe sepsis bundles

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ***6-hour severe sepsis bundle:*** Serum lactate measured.Blood cultures obtained prior to antibiotic administration.Initial empirical antibiotics administered within 1 h.In the event of hypotension and/or serum lactate \> 4 mmol/l:Deliver an initial minimum of 20 ml/kg of crystalloid (or colloid equivalent: 1.1 ml/kg of 20% albumin or 4.8 ml/kg of 6% hydroxyethyl starch).Apply vasopressors (noradrenaline or dopamine) for hypotension not responding to initial fluid resuscitation to maintain mean arterial pressure (MAP) ≥ 65 mm Hg.In the event of persistent septic shock and/or serum lactate \> 4 mmol/l, administration of inotropic dobutamine and/or transfusion of packed red blood cells (when haemoglobin (Hb) \< 70 g/l) to achieve a central venous pressure (CVP) of ≥ 8 mm Hg and central venous oxygen saturation (ScvO~2~) of ≥ 70%.
  ***24-hour severe sepsis bundle:*** Low dosage corticosteroid (40--60 mg/day of methylprednisolone) administered for septic shock requiring continued infusion of vasopressors.Glucose control maintained \< 8.3 mmol/l.For mechanically ventilated patients maintain inspiratory plateau pressures \< 30 cm H~2~O.
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Implementation of severe sepsis bundles {#S20006}
---------------------------------------

The 21-month implementation programme was organized into two continuous phases that incorporated education and intervention. During the education phase (in November 2006), conference lectures were delivered to all physicians and nurses in the RICU and the emergence department (ED) on the SSC, severe CAP definitions and recognition, haemodynamic monitoring, and the initiation and components of the bundles. Timely initiation and completion of the bundles were emphasized. Time zero was defined as the point when the diagnosis of severe CAP was established in the ED. Serum lactate measured, blood cultures obtained prior to antibiotic administration, and initial empirical antibiotics administered within 1 h were considered once severe CAP was diagnosed, and the admission was fulfilled through an Emergency Path. Insulin was intravenously administered by infusion pump to maintain blood glucose level \< 8.3 mmol/l. In the intervention phase (between 1 December 2006 and 31 July 2008), the personnel were issued with a personal pocket information card as a daily reminder of the processes involved in the delivery of the bundles and weekly feedback was provided by the senior physicians to all personnel in order to optimize compliance. The feedback incorporated oral information, cards posted in the RICU and the ED, and group discussions.

Definition of total compliance {#S20007}
------------------------------

On the basis of severity of illness, implementation of all necessary components of 6-hour, 24-hour, or 6/24-hour severe sepsis bundles was defined as total compliance. Had some components been unnecessary on the basis of the SSC, a patient would still have been regarded as receiving all components as long as the remaining ones were implemented.

Approval of study design {#S20008}
------------------------

The study was approved by our Institutional Review Boards (Review Board of Guangdong Medical College and Review Board of Guangzhou Medical University). Ethical approval from the regulation committee (Ethical Committee of Guangzhou) was granted for the study protocol with a waiver of informed consent.

Outcomes {#S20009}
--------

The primary outcomes were compliance and hospital mortality. Secondary outcomes incorporated ventilator-free days estimated from the ICU length of stay and parameters at 72 h after start of therapy. The endpoints for evaluation were referred to Kortgen\'s study \[[@CIT0009]\]. Laboratory variables were measured by the hospital clinical laboratory.

Grouping and data collection {#S20010}
----------------------------

One hundred and thirteen patients were enrolled in the cohort study period. Seven cases were excluded from this study according to the exclusion criteria. The remaining 106 patients, 46 (43.4%) patients who suffered from septic, shock were enrolled in the bundles group, which was further divided into the compliant and the non-compliant subgroups at the end of the study according to total compliance with 6/24-hour severe sepsis bundles. One hundred and six discharged patients who were selected through the formal case-control method to match all baseline characteristics of the patients in the prospective group were assigned to the control group. A senior physician was in charge of collecting the data. Demographics, co-morbid conditions, vital signs, laboratory data, and compliance data were collected. The volumes of 6% hydroxyethyl starch and 20% albumin were converted into equivalent dosages of crystalloid \[[@CIT0026]\]. Severity-of-illness scores were calculated, including the acute physiology and chronic health evaluation (APACHE) II scores and sequential organ failure assessment (SOFA) scores. Missing values were assumed to be normal \[[@CIT0027]\]. Indeed, patients with less severe illness were more likely to have missing values for laboratory findings. The statistician was blinded to the study and study hypothesis.

Statistical analysis {#S20011}
--------------------

All statistical analyses were performed with Statistical Package for the Social Science for Windows version 13.0 (SPSS, Chicago, IL, USA). Categorical variables and continuous data were reported as percentages and mean ± standard deviation (SD), respectively. Chi-square (χ^2^) test and independent-samples *t* test were used when appropriate in testing for differences between groups. Univariate and multivariate logistic regression analyses were employed. All components of severe sepsis bundles were entered into a multivariate logistic regression model. Statistical significance was defined as *p* \< 0.05.

Results {#S0012}
=======

Baseline characteristics of patients {#S20013}
------------------------------------

No significant differences were observed between the two patient groups with respect to baseline characteristics ([Table II](#T0002){ref-type="table"}). The aetiologies were not detected in many patients in the control group. Hence, the data were not shown. The initial antibiotic regimens in the two groups were consistent with the guidelines on the management of CAP \[[@CIT0003], [@CIT0028]\], in addition to subsequently cultured pathogens. All patients in the bundles group had central venous pressure (CVP) and central venous oxygen saturation (ScvO~2~) measured and the averages were 9.4 ±1.7 mm Hg and 68.3 ±9.8%, respectively. However, these parameters were not measured in most patients in the control group. Therefore, the comparison could not be drawn.

###### 

Baseline characteristics of patients (mean ± SD, *n* = 212)

  Variable                                             Control group   Bundles group   Value of χ^2^ or *t*   Value of *p*
  ---------------------------------------------------- --------------- --------------- ---------------------- --------------
  Age \[years\]                                        62.8 ±14.2      64.0 ±15.2      0.941                  0.348
  Male sex (%)                                         77.4            66.1            3.347                  0.067
  Body temperature \[°C\]                              37.6 ±1.0       37.8 ±1.3       1.485                  0.149
  Heart rate \[beats/min\]                             113.6 ±22.4     116.4 ±27.6     0.827                  0.409
  Respiratory rate \[breaths/min\]                     29.0 ±6.7       29.9 ±10.0      0.780                  0.436
  MAP \[mm Hg\]                                        81.1 ±18.2      81.0 ±19.9      0.035                  0.972
  Blood glucose \[mmol/l\]                             9.0 ±2.6        9.1 ±3.3        0.248                  0.804
  White blood cell count \[10^9^/l\]                   13.6 ±7.5       15.0 ±6.6       1.532                  0.127
  PaO~2~/FIO~2~ \[mm Hg\]                              141.5 ±42.9     150.2 ±58.4     1.236                  0.218
  Serum creatinine \[µmol/l\]                          106.4 ±53.9     111.7 ±79.6     0.568                  0.571
  Total bilirubin \[µmol/l\]                           25.3 ±38.9      29.0 ±69.9      0.469                  0.639
  Alanine aminotransferase \[U/l\]                     88.0 ±155.5     58.7 ±115.0     1.559                  0.121
  Platelets \[10^9^/l\]                                211.7 ±108.7    205.1 ±94.4     0.470                  0.639
  Haematocrit (%)                                      33.6 ±6.4       32.9 ±6.5       0.815                  0.416
  Serum lactate \[mmol/l\]                             2.8 ±1.4        3.1 ±1.5        0.748                  0.465
  APACHE II score                                      15.4 ±5.3       15.9 ±7.5       0.991                  0.317
  SOFA score                                           6.1 ±3.4        6.9 ±4.7        1.464                  0.145
  Shock (%)                                            37.7            43.4            0.704                  0.401
  Comorbidities (%):                                                                                          
   Hypertension                                        38.4            40.6            0.265                  0.529
   Coronary heart disease                              11.3            6.6             1.445                  0.229
   Heart failure                                       12.3            10.4            0.188                  0.665
   Chronic obstructive pulmonary disease               26.4            33.0            1.107                  0.293
   Diabetes mellitus                                   14.2            18.9            0.856                  0.355
   Liver disease                                       7.5             9.4             0.243                  0.622
   Tumour                                              19.8            11.3            2.907                  0.088
   Nervous system disease                              7.5             9.4             0.243                  0.622
   Chronic renal insufficiency                         7.5             5.7             0.306                  0.580
  Alcohol abuse (%)                                    5.7             1.9             2.078                  0.149
  Smoking (%)                                          34.9            35.8            0.021                  0.886
  Duration to establish severe CAP diagnosis \[min\]   61.8 ±57.2      60.3 ±49.5      0.253                  0.712
  Antibiotic therapy:                                                                                         
   Antibiotics adequate (%)                            93.7            95.8            0.319                  0.527
   Duration \[days\]                                   12.6 ±14.3      12.9 ±15.1      0.237                  0.872

PaO~2~/FIO~2~ -- arterial oxygen pressure/fraction inspired oxygen.

Compliance with severe sepsis bundles {#S20014}
-------------------------------------

Compliance with administration of antibiotics within 1 h, administration of vasopressors (if necessary), and plateau pressure on average \< 30 cm H~2~O was high in both groups (*p*, 0.206, 0.085, 0.149, respectively; [Figure 1](#F0001){ref-type="fig"}). Significant differences were found between the two groups with respect to serum lactate measured, blood cultures obtained prior to antibiotic administration, initiation of fluid resuscitation and volumes infused, administration of inotropic dobutamine and/or transfusion of packed red blood cells, low-dose steroids (if necessary), and glucose control (*p*, \< 0.001, 0.001, \< 0.001, 0.005, \< 0.001, and \< 0.001, respectively; [Figure 1](#F0001){ref-type="fig"}). Inotropic dobutamine was administered to 17 patients, 11 patients simultaneously received an average 4-unit transfusion of packed red cells in the bundles group, whereas the numbers in the control group were 4, 2, and 2, respectively. The average volume infused within 6 h in the bundles group was more than that in the control group (1319.8 ±1107.4 ml vs. 461.9 ±799.3 ml; *p* \< 0.001). The rates of total compliance with 6-hour, 24-hour, and 6/24-hour bundles in the bundles group were 47.1%, 51.9%, and 42.5%, whereas the rates in the control group were 0.0%, 0.0%, and 0.0% (*p*, \< 0.001, \< 0.001, and \< 0.001), respectively.

![Compliance with components of severe sepsis bundles (*n* = 212)\
RBC -- red blood cells](AMS-10-23761-g001){#F0001}

Outcomes at 72 hours {#S20015}
--------------------

Significant differences were observed between the two groups in respiratory rate, MAP, blood glucose, arterial oxygen pressure/fraction inspired oxygen (PaO~2~/FIO~2~), serum creatinine, serum lactate, APACHE II scores, and SOFA scores at 72 h after the start of therapy ([Table III](#T0003){ref-type="table"}). Central venous pressure increased significantly from 9.4 ±1.7 mm Hg at baseline to 10.9 ±1.8 mm Hg at 72 h after the start of therapy in the bundles group (*p* \< 0.001), as did ScvO~2~ during this time period (68.3 ±9.8% vs. 79.5 ±3.8%, *p* \< 0.001).

###### 

Outcomes at 72 h (mean ± SD, *n* = 212)

  Parameter                            Control group   Bundles group   Value of *t*   Value of *p*
  ------------------------------------ --------------- --------------- -------------- --------------
  Body temperature \[°C\]              37.2 ±1.0       37.3 ±0.9       0.236          0.814
  Heart rate \[beats/min\]             100.3 ±21.5     99.7 ±17.5      0.214          0.831
  Respiratory rate \[breaths/min\]     27.7 ±7.0       25.2 ±7.6       2.542          0.012
  MAP \[mm Hg\]                        87.8 ±12.9      91.4 ±10.6      2.185          0.030
  Blood glucose \[mmol/l\]             8.9 ±2.3        7.4 ±1.8        5.360          \< 0.001
  White blood cell count \[10^9^/l\]   13.0 ±8.9       14.2 ±7.5       1.034          0.302
  PaO~2~/FIO~2~ \[mm Hg\]              172.4 ±101.6    223.1 ±83.3     3.971          \< 0.001
  Serum creatinine \[µmol/l\]          118.3 ±87.5     97.0 ±52.6      2.145          0.033
  Total bilirubin \[µmol/l\]           33.7 ±64.9      35.7 ±98.9      0.179          0.858
  Alanine aminotransferase \[U/l\]     254.8 ±1219.2   51.2 ±50.9      1.718          0.087
  Platelets \[10^9^/l\]                159.6 ±109.8    162.0 ±112.3    0.161          0.872
  Haematocrit (%)                      30.7 ±5.4       29.8 ±5.3       1.229          0.221
  Serum lactate \[mmol/l\]             4.1 ±3.9        2.5 ±0.7        2.979          0.004
  APACHE II score                      11.3 ±5.7       9.5 ±4.7        2.637          0.009
  SOFA score                           6.6 ±4.1        5.4 ±4.3        2.170          0.031

Hospital mortality and ventilator-free days {#S20016}
-------------------------------------------

Hospital mortality in patients enrolled in the bundles group compared with that in the control group was 29.2% vs. 44.3% (χ^2^ = 5.192, *p* = 0.023), reflecting a 15.1% absolute reduction in mortality. There was a significantly decreased odds ratio (OR) for mortality in patients who received bundles treatment (OR = 0.393; 95% confidence interval (CI), 0.209--0.741; *p* = 0.004). A multivariate logistic regression analysis was performed. Serum lactate measured, blood cultures obtained prior to antibiotic administration, and fluid resuscitation showed independent relationships with decreased mortality (OR = 0.112, 0.459, and 0.247; 95% CI: 0.037--0.334, 0.211--0.997, and 0.091--0.635; *p*, \< 0.001, 0.039, and \< 0.001; respectively).

The two subgroups were comparable with respect to age, gender, and severity at baseline ([Table IV](#T0004){ref-type="table"}). Compared with the non-compliant subgroup, the compliant subgroup had a more than twofold decrease in mortality (17.8% vs. 37.7%. OR = 0.222; 95% CI: 0.082--0.602; *p* = 0.003).

###### 

Baseline characteristics of patients and mortality in the bundles group according to total compliance (mean ± SD, *n* = 106)

  Parameter                            Compliant subgroup (*n* = 45)   Non-compliant subgroup (*n* = 61)   Value of χ^2^ or *t*   Value of *p*
  ------------------------------------ ------------------------------- ----------------------------------- ---------------------- --------------
  Age \[years\]                        61.7 ±19.2                      61.4 ±15.5                          0.096                  0.924
  Male sex (%)                         68.9                            63.9                                0.283                  0.594
  MAP \[mm Hg\]                        81.6 ±21.0                      80.5 ±19.2                          0.289                  0.773
  White blood cell count \[10^9^/l\]   16.5 ±7.4                       14.0 ±5.7                           1.926                  0.048
  PaO~2~/FIO~2~ \[mm Hg\]              145.3 ±63.2                     162.1 ±52.2                         1.460                  0.148
  APACHE II score                      16.9 ±7.3                       15.2 ±7.6                           1.206                  0.231
  SOFA score                           7.4 ±5.3                        6.0 ±4.0                            1.470                  0.146
  Shock (%)                            44.4                            31.1                                1.969                  0.161
  Mortality, *n* (%)                   8 (17.8)                        23 (37.7)                           4.970                  0.026

All patients in both groups were mechanically ventilated. In the bundles group, patients had significant longer ventilator-free days compared with such patients in the control group (6.1 ±6.7 vs. 3.9 ± 6.6 days; *p* = 0.017).

Discussion {#S0017}
==========

Compliance with administration of antibiotics and vasopressors and plateau pressure on average \< 30 cm H~2~O was high. The rates of total compliance with the bundles in the prospective period increased significantly. Hospital mortalities were significantly reduced in the bundles group and in the compliant subgroup. Serum lactate measurement, blood cultures, and fluid resuscitation were independently associated with decreased mortality.

Initial empirical antibiotics were generally administered within 1 h, suggesting that our physicians know and readily accept the concept of the association between timing of antibiotic administration and outcomes \[[@CIT0029]--[@CIT0031]\]. Nguyen *et al*. \[[@CIT0032]\] found that physicians were more willing to accept hypotension than serum lactate concentration as a criterion to initiate resuscitation, as in the current study; that is to say, some patients with serum lactate \> 4 mmol/l might not receive fluid resuscitation. Therefore, compliance with initiation of fluid resuscitation was not high. Compliance with administration of vasopressors was high in both groups, but the implementation of administration of inotropic dobutamine and/or transfusion of packed red blood cells was poor (the worst), suggesting that our physicians did not put more emphasis on the imbalance between oxygen consumption and supply when dealing with persistent septic shock. Glucose control was the lowest compliant element of the 24-hour bundle in our study despite continuous insulin infusion. Scrupulous avoidance of iatrogenic hypoglycaemia frequently resulted in blood glucose \> 8.3 mmol/l.

Our physicians found that weekly feedback facilitated the implementation of the bundles. Levy *et al*. \[[@CIT0013]\] also reported that compliance with the entire resuscitation bundle and with the entire management bundle increased to 31.3% and 36.1%, respectively, by the end of 2 years. The compliance rate with all elements of the sepsis resuscitation bundle increased from 12.7% at baseline to 37.7% and 53.7% during the weekly feedback and sepsis response team activation periods, respectively (*p* \< 0.001) \[[@CIT0033]\]. Compliance with a 6-hour severe sepsis bundle at the beginning was low and increased by the end (from 8.1% to 53.7%) \[[@CIT0008]\].

The total compliance was not high in the current study, as was it in Phua\'s study (compliance rates for the resuscitation and management bundles were 7.6% and 3.5%, respectively) \[[@CIT0022]\] and Schramm\'s study (the compliance rate with all elements of the sepsis resuscitation bundle increased from 12.7% at baseline to 37.7% and 53.7% during the weekly feedback and sepsis response team activation periods, respectively) \[[@CIT0033]\]. Two of the major factors limiting high total compliance in our study might be lack of sufficient staff in the RICU and the ED and difficulty in maintaining the time intervals. This is likely to be improved by better staff awareness of the benefits and timeliness of implementing the bundles. Levy\'s report emphasized the importance of early management and was reminiscent of the concept of the golden 6 h and silver 24 h for trauma \[[@CIT0034]\].

The SSC has had some impact; however, there is still a long way to go \[[@CIT0035]\]. What about the feasibility of implementing the bundles in undeveloped countries? Our institution is the state key laboratory of respiratory diseases. This might be envisaged to interpret the higher compliance in the current study, compared with that in Phua\'s multicentre study \[[@CIT0022]\]. It is likely to imply that the implementation of the bundles might be very arduous in many undeveloped countries, especially those in Asia. This might be an important message that would have potential to improve care on a global basis. Hence, future long-term multicentre studies should be performed to assess the compliance in limited resources countries.

The patients without hypotension would still have received fluid resuscitation had serum lactate been measured, which could be of survival benefit. Similarly, obtaining blood cultures may be useful if the blood cultures revealed a pathogen that was not being treated effectively with the antibiotics chosen. If the clinician was then able to act upon that information and correct the antibiotic choice, this could have an impact on mortality. These considerations might explain why serum lactate measured and blood cultures showed independent relationships with decreased mortality.

Our current data revealed the pivotal role of implementing severe sepsis bundles in the management of severe CAP. The 15.1% absolute hospital mortality reduction in our study was similar to that reported by Nguyen *et al*. (18.7%) \[[@CIT0008]\], Kortgen *et al*. (26%) \[[@CIT0009]\], Micek *et al*. (18.3%) \[[@CIT0011]\], Lefrant *et al*. (13.0%) \[[@CIT0016]\], Schramm *et al*. (8.3%) \[[@CIT0033]\], and Castellanos-Ortega *et al*. (19.8%) \[[@CIT0036]\]. In the compliant subgroup, patients had a more than twofold decrease in mortality compared with such patients in the non-compliant subgroup in the current study. Gao *et al*. \[[@CIT0007]\] reported that the mortality in the compliant group decreased from 49% to 23% (*p* = 0.01), compared with the non-compliant group. Mortality was 61.1% in the non-bundle group versus 20% with the bundle (*p* \< 0.001) \[[@CIT0015]\]. Delivery of the interventions had an association with reduced mortality: for the sepsis six, 20.0% compared with 44.1% (*p* \< 0.001); for the resuscitation bundle, 5.9% compared with 51% (*p* \< 0.001) \[[@CIT0014]\].

Several limitations of this study deserve comment. Comparing crude mortality rates before and after an intervention ignores the underlying trend of decreased mortality and might give rise to misleading conclusions. Another limitation is that it was performed only in patients with severe CAP and not other types of sepsis from other sources of infection such as intra-abdominal infections or soft tissue infections. There might be some imbalance in the aetiology of pneumonia between the two groups. The study was not multicentre. Finally, long-term follow-up was not done; therefore, it was uncertain whether the implementation of the bundles and its effect would be similar to what Ferrer *et al*. \[[@CIT0037]\] reported (during long-term follow-up, compliance with the sepsis resuscitation bundle returned to baseline but compliance with the sepsis management bundle and mortality remained stable with respect to the post-intervention period).

In conclusion, total compliance was relatively low, but the implementation of severe sepsis bundles was associated with a significant decrease in mortality from severe CAP.
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